SLI Medical Acceptable Dating: we will ship >= 90 days
UNSPSC Code
Requires Refrigeration
User
Oral
Volume
51201618
Indicated for People 6 to 32 Weeks of Age
2 mL
Features
RotaTeq® is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by types G1
G2
G3
G4
and G9
RotaTeq is approved for use in infants 6 weeks to 32 weeks of age
The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age
with the subsequent doses administered at 4 to 10 week intervals
Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap
allowing for direct oral administration
The dosing tube is contained in a pouch
Package of 25 individually pouched single-dose tubes
